The Urokinase Plasminogen Activator System: Role in Malignancy
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
39-49
Author(s):
Michael J. Duffy
Resistance to Anti-VEGF Agents
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
51-64
Author(s):
Ton N. C. and Jayson G. C.
Molecular Targeting of Lymphatics for Therapy
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
65-74
Author(s):
S. A. Stacker, R. A. Hughes and M. G. Achen
Development and Engineering of Lymphatic Endothelial Cells: Clinical Implications
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
75-80
Author(s):
Jorg Wilting and Lothar Schweigerer
Use of ‘Omic’ Approaches in Unraveling Mechanisms of Gene-Environment Interactions
Journal:
Current Genomics
Volume:
5
Page:
1-6
Author(s):
Kenneth Olden
Subject Index to Volume 10
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
115-132
Author(s):
Bentham Science Publishers
Fibroblast Growth Factor 2: From Laboratory Evidence to Clinical Application
Journal:
Current Vascular Pharmacology
Volume:
2
Page:
33-43
Author(s):
Chu-Huang Chen, Simon M. Poucher, Jonathan Lu and Philip D. Henry
Rhenium-188 and Copper-67 Radiopharmaceuticals for the Treatment of Bladder Cancer
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
4
Page:
61-68
Author(s):
M. Frier
Preface
Journal:
Current Topics in Medicinal Chemistry
Volume:
4
Page:
i-i
Author(s):
Antonio Espinosa
Thymidine Phosphorylase Over-Expression in Oral Squamous Carcinoma Tissue as a Potential Target of Capecitabine
Journal:
Letters in Drug Design & Discovery
Volume:
1
Page:
45-49
Author(s):
G. Ranieri, R. Patruno, G. Fiore, G. Saponaro, A. Paradiso and L. Grammatica